Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
146
CIMA_AEMPS:97
EMA:40
NMPA:9
Drug Approvals
Alectinib Hydrochloride Capsules
- Product Name
- 安圣莎
- Approval Number
- 国药准字HJ20180047
- Approval Date
- Jan 10, 2024
NMPA
Tocilizumab Injection (Subcutaneous Injection)
- Product Name
- 托珠单抗注射液(皮下注射)
- Approval Number
- 国药准字SJ20220013
- Approval Date
- Apr 8, 2022
NMPA
Vemurafenib film-coated tablets
- Product Name
- 佐博伏
- Approval Number
- 国药准字HJ20170124
- Approval Date
- Jan 17, 2022
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 特罗凯
- Approval Number
- 国药准字HJ20160395
- Approval Date
- Nov 17, 2020
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 特罗凯
- Approval Number
- 国药准字HJ20160394
- Approval Date
- Nov 17, 2020
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 特罗凯
- Approval Number
- 国药准字HJ20160392
- Approval Date
- Nov 17, 2020
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 特罗凯
- Approval Number
- 国药准字HJ20170143
- Approval Date
- Nov 17, 2020
NMPA
Clinical Trials
No trials found
News
No news found